Janssen bags new EU approval for Darzalex
Janssen’s Darzalex has been approved in Europe for the first-line treatment of patients with multiple myeloma.
Read More
Tag: VMP
Darzalex combo wins nod for newly diagnosed multiple myeloma
Janssen’s Darzalex has become the first monoclonal antibody to be approved in the US to treat patients newly diagnosed with multiple myeloma.
Read More
J&J’s Darzalex shows promise in newly-diagnosed multiple myeloma
Johnson & Johnson group Janssen has unveiled new data showing a 50 percent cut in the risk of disease progression or death in patients with newly diagnosed multiple myeloma given Darzalex on top of standard treatment.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
